Evidence map›Paper›PMID 34740959›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis.

Eric J Allenspach, Nicholas J Shubin, Karen Cerosaletti, Carmen Mikacenic, Jacquelyn A Gorman, Matthew A MacQuivey, Aaron B I Rosen, Andrew E Timms, Michelle N Wray-Dutra, Kerri Niino and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Eric J AllenspachCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; drawling@uw.edu ealle2@uw.edu.ORCID 0000-0001-7346-5835
Nicholas J ShubinCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Karen CerosalettiCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.ORCID 0000-0002-7403-6239
Carmen MikacenicCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.
Jacquelyn A GormanCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Matthew A MacQuiveyCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Aaron B I RosenCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Andrew E TimmsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-8808-4012
Michelle N Wray-DutraCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
Kerri NiinoCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0003-1989-9100
Denny LiggittDepartment of Comparative Medicine, University of Washington, Seattle, WA.ORCID 0000-0003-4511-1700
Mark M WurfelDepartment of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA.
Jane H BucknerCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.ORCID 0000-0002-9005-1885
Adrian M PiliponskyCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
David J RawlingsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; drawling@uw.edu ealle2@uw.edu.ORCID 0000-0002-0810-1776
University of Washington · USVirginia Mason Medical Center · US

Funding

RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
An integrated strategy to define the functional and synergistic impact of T1D causal variantsDP3DK111802 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2016 to 2016
$4.4M
Defining the functional impact of T1D genes in mouse and man: a unified strategyDP3DK097672 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI BUCKNER, JANE HOYT · 2012 to 2013
$4.4M
Critical Role of Basophils in the Enhancement of the Innate Immune Response during SepsisR01HL141094 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI PILIPONSKY, ADRIAN M · 2018 to 2021
$3.0M
The Role of the Adaptor Protein SH2B3 in Type 1 DiabetesK08DK114568 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI ALLENSPACH, ERIC J · 2018 to 2022
$810k
The role of SH2B3 in regulating CD8 T cells in Type 1 DiabetesR03DK134746 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI ALLENSPACH, ERIC J · 2023 to 2024
$289k
NHLBI NIH HHS R01 HL141094NIAMS NIH HHS T32 AR007108NIDDK NIH HHS DP3 DK097672NIDDK NIH HHS DP3 DK111802NIDDK NIH HHS K08 DK114568NIDDK NIH HHS R03 DK134746
6 · The paper itself

Abstract

The single-nucleotide polymorphism (SNP) rs3184504 is broadly associated with increased risk for multiple autoimmune and cardiovascular diseases. Although the allele is uniquely enriched in European descent, the mechanism for the widespread selective sweep is not clear. In this study, we find the rs3184504*T allele had a strong association with reduced mortality in a human sepsis cohort. The rs3184504*T allele associates with a loss-of-function amino acid change (p.R262W) in the adaptor protein SH2B3, a likely causal variant. To better understand the role of SH2B3 in sepsis, we used mouse modeling and challenged SH2B3-deficient mice with a polymicrobial cecal-ligation puncture (CLP) procedure. We found SH2B3 deficiency improved survival and morbidity with less organ damage and earlier bacterial clearance compared with control mice. The peritoneal infiltrating cells exhibited augmented phagocytosis in

Indexed as

Adaptor Proteins, Signal TransducingAdultAnimalsDisease Models, AnimalHumansMiceMice, CongenicMice, Inbred C57BLMice, KnockoutMice, TransgenicPolymorphism, Single NucleotideSepsisAdaptor Proteins, Signal Transducing

Identifiers

PMID34740959
PMCPMC8612972
OpenAlexW3211189873

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.